Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury
NCT04819685 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 520
Last updated 2021-03-29
Summary
A total of 520 cases will be randomly divided into Kang Fu Pen (liquid dressing) enema intervention group (experimental group) and non-enema intervention group (control group), according to the ratio of 1:1.
Conditions
- Cervical Cancer
- Radiotherapy Side Effect
- Radiotherapy; Complications
Interventions
- DRUG
-
KANG FU PEN
FU PEN: anti-radiation spray (liquid dressing) treatment which is a protective irrigation solution against rays
Sponsors & Collaborators
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
collaborator OTHER -
Chinese PLA General Hospital
collaborator OTHER -
Peking University Third Hospital
collaborator OTHER -
Peking University Cancer Hospital & Institute
collaborator OTHER -
Jiangsu Cancer Institute & Hospital
collaborator OTHER -
Sichuan Cancer Hospital and Research Institute
collaborator OTHER -
Sun Yat-sen University
collaborator OTHER -
Jilin Provincial Tumor Hospital
collaborator OTHER -
Fudan University
collaborator OTHER -
Shandong Cancer Hospital and Institute
collaborator OTHER -
The First Affiliated Hospital of Air Force Medicial University
collaborator OTHER -
Guizhou Cancer Hospital (The Affiliated Cancer Hospital of Guizhou Medical University)
collaborator UNKNOWN -
Zhejiang Cancer Hospital
collaborator OTHER -
Xiangya Hospital of Central South University
collaborator OTHER -
Henan Cancer Hospital
collaborator OTHER_GOV -
Peking Union Medical College Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2023-03-01
- Completion
- 2025-03-01
Countries
- China
Study Locations
More Related Trials
-
Sigmoid Colon Organ Motion in Radiotherapy
NCT03259828 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Subsequent Treatments After Radical Surgery
NCT00806117 ·Status: UNKNOWN ·Phase: PHASE3
-
Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
NCT05316103 ·Status: RECRUITING ·Phase: NA
-
A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer
NCT01310985 ·Status: COMPLETED
-
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
NCT02992886 ·Status: COMPLETED ·Phase: PHASE2
-
An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients
NCT03885505 ·Status: UNKNOWN
-
FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study
NCT02887313 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer
NCT04801511 ·Status: UNKNOWN ·Phase: PHASE2
-
RT for Cervical Adenocarcinoma/adenosquamous Carcinoma
NCT06741046 ·Status: ACTIVE_NOT_RECRUITING
-
Irreversible Electroporation(IRE) For Uterine Cervical Neoplasms
NCT02430610 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation for Radiation-Induced Proctopathy
NCT06776029 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Different Radiation Dosimetry for Anorectal Function of Patients With Pelvic Cancer
NCT05832385 ·Status: NOT_YET_RECRUITING
-
CTV Exploration of 3D-PT Assisted CT-guided I-125 Seeds Implantation for Recurrent Rectal Cancer
NCT04710589 ·Status: UNKNOWN
-
Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury
NCT06325982 ·Status: RECRUITING ·Phase: NA
-
Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
NCT05682950 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer
NCT04558684 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Irradiation Modulates the Pharmacokinetics of Anticancer Drugs
NCT01755585 ·Status: UNKNOWN
-
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer
NCT05310305 ·Status: UNKNOWN
-
A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic Radiotherapy
NCT07053761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients
NCT01268943 ·Status: COMPLETED ·Phase: PHASE1
-
Carbon Nanoparticles as Lymph Node Tracer in Rectal Cancer After Neoadjuvant Radiochemotherapy
NCT03550001 ·Status: UNKNOWN ·Phase: NA
-
Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
NCT06364384 ·Status: RECRUITING ·Phase: PHASE2
-
the Re-irradiation of Recurrent Cervical Cancer by IMRT
NCT03170570 ·Status: UNKNOWN ·Phase: NA
-
Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody
NCT06014944 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
NCT04808323 ·Status: RECRUITING ·Phase: PHASE1